| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |